Treatments for COVID-19, gout, nicotine dependence, severe hypertriglyceridemia, and thyroid eye disease are under review.
The pause issued by Alito will last until at least May 11, according to The Times, when the full court will then determine how to move forward. HealthDay News — US Supreme Court Justice Samuel Alito ...
Real-time continuous glucose monitoring (CGM) improves blood glucose management in adults with type 2 diabetes managed with basal insulin, according to a study ...
Topline data from the ACACIA-HCM study reveal that the cardiac myosin inhibitor aficamten met all primary and key secondary endpoints, offering a potential new treatment pathway for patients with ...
A larger percentage of patients in PFA group had treatment success at 12 months compared with those receiving antiarrhythmic-drug therapy.
Tazbentetol is an investigational, once-daily synaptic regenerative therapy designed to restore cognitive and motor function in ALS.
About one-quarter of large outbreak-related cases ID'd through contact tracing; they less often had clinical markers of highly infectious disease ...
The approval is supported by bioequivalence data assessing the once-daily extended-release formulation to twice-daily immediate-release ruxolitinib in healthy participants.
Vaccinations administered alone or sequentially are safe and effective, providing high RSV-A, -B nAb titers in infants ...
The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.
Clinical data from a 16-patient pediatric study demonstrate the safety and efficacy of Asceniv in younger populations, ...
Nereus ™ (tradipitant) is now available for the prevention of vomiting induced by motion in adults. According to manufacturer Vanda Pharmaceuticals, the product is available by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results